D. Western Therapeutics Institute, Inc.
π―π΅Japan
Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Open-Label Study of Safety of H1337 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Glaucoma Open-Angle PrimaryOcular Hypertension
- Interventions
- Drug: H-1337 1.0%
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- D. Western Therapeutics Institute, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT06572397
- Locations
- πΊπΈ
Eye Research Foundation Inc., Newport Beach, California, United States
Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Ocular HypertensionGlaucoma Open-Angle Primary
- Interventions
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2025-08-27
- Lead Sponsor
- D. Western Therapeutics Institute, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT05913232
- Locations
- πΊπΈ
Global Research Management, Glendale, California, United States
πΊπΈSkyline Vision Clinic and Laser Center, Colorado Springs, Colorado, United States
πΊπΈCentral Florida Eye Associates, Lakeland, Florida, United States
News
No news found